Skip to main content
. 2021 Jul 19;11(7):e048243. doi: 10.1136/bmjopen-2020-048243

Figure 3.

Figure 3

Nomogram based on the competing-risks analysis to predict CSD probabilities at 3, 5 and 8 years for patients with upper tract urothelial carcinoma. CSD, cancer-specific death; LNP, lymph nodes positive; LNR, lymph nodes ratio.